共 50 条
- [21] Fluvoxamine for outpatients with COVID-19: where do we stand? LANCET GLOBAL HEALTH, 2022, 10 (01): : E2 - E3
- [29] Why we should not recommend or offer fluvoxamine to COVID-19 patients? European Journal of Clinical Pharmacology, 2023, 79 : 321 - 322
- [30] Heme oxygenase agonists—fluvoxamine, melatonin—are efficacious therapy for Covid-19 Cell Stress and Chaperones, 2022, 27 : 3 - 4